JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
The Japanese Foundation for Cancer Research (JFCR), NEC Corporation (NEC), and Taiho Pharmaceutical Co., Ltd. (Taiho) have signed a three-party joint research (Joint Research) agreement aimed at developing new cancer vaccines through the utilization of whole-genome information. This Joint Research project will be carried out as part of the Japan Agency for Medical Research and […]